RWA Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.4M | Buy |
48,114
+456
| +1% | +$156K | 0.17% | 81 |
|
|
2026
Q1 | $16.8M | Sell |
47,658
-95
| -0.2% | -$33.9K | 0.18% | 78 |
|
|
2025
Q4 | $15.6M | Buy |
47,753
+2,540
| +6% | +$806K | 0.17% | 81 |
|
|
2025
Q3 | $12.8M | Buy |
45,213
+10,588
| +31% | +$3.07M | 0.14% | 90 |
|
|
2025
Q2 | $9.67M | Buy |
34,625
+16
| +0% | +$4.53K | 0.12% | 108 |
|
|
2025
Q1 | $10.8M | Buy |
34,609
+2,270
| +7% | +$670K | 0.14% | 95 |
|
|
2024
Q4 | $8.43M | Sell |
32,339
-838
| -3% | -$249K | 0.1% | 110 |
|
|
2024
Q3 | $10.7M | Buy |
33,177
+315
| +1% | +$103K | 0.13% | 97 |
|
|
2024
Q2 | $10.3M | Buy |
32,862
+321
| +1% | +$94.3K | 0.14% | 97 |
|
|
2024
Q1 | $9.25M | Buy |
32,541
+4,160
| +15% | +$1.22M | 0.12% | 102 |
|
|
2023
Q4 | $8.17M | Buy |
28,381
+9,541
| +51% | +$2.6M | 0.12% | 104 |
|
|
2023
Q3 | $5.06M | Buy |
18,840
+1,266
| +7% | +$316K | 0.11% | 83 |
|
|
2023
Q2 | $3.9M | Buy |
17,574
+13,936
| +383% | +$3.23M | 0.09% | 91 |
|
|
2023
Q1 | $879K | Sell |
3,638
-71
| -2% | -$17.4K | 0.02% | 140 |
|
|
2022
Q4 | $1.01M | Sell |
3,709
-177
| -5% | -$47.4K | 0.03% | 130 |
|
|
2022
Q3 | $876K | Sell |
3,886
-283
| -7% | -$68.6K | 0.06% | 131 |
|
|
2022
Q2 | $1.01M | Sell |
4,169
-26,275
| -86% | -$6.44M | 0.07% | 124 |
|
|
2022
Q1 | $7.36M | Buy |
30,444
+2,168
| +8% | +$498K | 0.48% | 58 |
|
|
2021
Q4 | $6.36M | Sell |
28,276
-1,125
| -4% | -$237K | 0.43% | 67 |
|
|
2021
Q3 | $6.25M | Buy |
29,401
+427
| +1% | +$98.3K | 0.47% | 62 |
|
|
2021
Q2 | $7.06M | Buy |
28,974
+707
| +3% | +$174K | 0.53% | 54 |
|
|
2021
Q1 | $7.03M | Buy |
28,267
+4,995
| +21% | +$1.19M | 0.57% | 51 |
|
|
2020
Q4 | $5.35M | Sell |
23,272
-527
| -2% | -$122K | 0.47% | 60 |
|
|
2020
Q3 | $6.05M | Buy |
23,799
+1,771
| +8% | +$439K | 0.64% | 41 |
|
|
2020
Q2 | $5.2M | Buy |
22,028
+1,309
| +6% | +$299K | 0.64% | 44 |
|
|
2020
Q1 | $4.2M | Sell |
20,719
-1,598
| -7% | -$349K | 0.6% | 43 |
|
|
2019
Q4 | $5.38M | Buy |
22,317
+876
| +4% | +$193K | 0.53% | 48 |
|
|
2019
Q3 | $4.15M | Sell |
21,441
-140
| -0.6% | -$26.9K | 0.44% | 56 |
|
|
2019
Q2 | $3.98M | Sell |
21,581
-346
| -2% | -$62K | 0.43% | 57 |
|
|
2019
Q1 | $4.17M | Buy |
21,927
+645
| +3% | +$123K | 0.48% | 51 |
|
|
2018
Q4 | $4.14M | Buy |
21,282
+539
| +3% | +$105K | 0.55% | 49 |
|
|
2018
Q3 | $4.3M | Buy |
20,743
+173
| +0.8% | +$34.1K | 0.48% | 44 |
|
|
2018
Q2 | $3.8M | Buy |
20,570
+551
| +3% | +$97.5K | 0.42% | 56 |
|
|
2018
Q1 | $3.41M | Sell |
20,019
-8,600
| -30% | -$1.58M | 0.44% | 60 |
|
|
2017
Q4 | $4.98M | Buy |
28,619
+48
| +0.2% | +$8.49K | 0.56% | 48 |
|
|
2017
Q3 | $5.33M | Buy |
28,571
+432
| +2% | +$76.5K | 0.6% | 43 |
|
|
2017
Q2 | $4.85M | Buy |
28,139
+967
| +4% | +$157K | 0.59% | 42 |
|
|
2017
Q1 | $4.46M | Buy |
+27,172
| New | +$4.51M | 0.58% | 43 |
|
Other funds holding AMGN
RWA Wealth Partners's AMGN Position: Q2 2026 in Review
RWA Wealth Partners increased its Amgen (AMGN) stake by 0.96% in Q2 2026, buying an estimated $156K and bringing the position to 48,114 shares worth $17.4M. The position accounts for 0.17% of the portfolio, ranked #81.
RWA Wealth Partners first reported a position in AMGN in Q1 2017 and has held it in 38 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- RWA Wealth Partners held 48,114 shares of Amgen worth $17.4M as of Q2 2026.
- RWA Wealth Partners bought 456 Amgen shares in Q2 2026, an estimated $156K.
- Amgen made up 0.17% of RWA Wealth Partners's portfolio in Q2 2026, its #81 holding.
- RWA Wealth Partners first reported a position in Amgen in Q1 2017 and has held it in 38 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.